MICROBOT MEDICAL INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
MICROBOT MEDICAL INC. (MBOT) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $13.13 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2016-03-15
- MICROBOT MEDICAL INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2015 was $13.13M, a 23.17% increase from fiscal 2014.
- MICROBOT MEDICAL INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2014 was $10.66M, a 3.77% increase from fiscal 2013.
- MICROBOT MEDICAL INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2013 was $10.27M, a 1088.66% increase from fiscal 2012.
- MICROBOT MEDICAL INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2012 was $864.00K, a 89.02% decline from fiscal 2011.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2015-12-31 | $13.13M 10-K · filed 2016-03-15 |
| 2014-12-31 | $10.66M 10-K · filed 2016-03-15 |
| 2013-12-31 | $10.27M 10-K · filed 2015-03-13 |
| 2012-12-31 | $864.00K 10-K · filed 2014-03-13 |
| 2011-12-31 | $7.87M 10-K · filed 2013-03-21 |
| 2010-12-31 | $7.03M 10-K · filed 2013-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |